Vergleich

GW441756 hydrochloride Europäischer Partner

ArtNr ALO-G-191-25mg
Hersteller Alomone
CAS-Nr. 504433-24-3
Menge 25 mg
Quantity options 10 mg 25 mg 50 mg 5 mg
Kategorie
Typ Small Molecules
Format Lyophilized
Specific against other
Purity ≥97%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Type
Non Antibodies
Manufacturer - Category
S. Molecules
Manufacturer - Targets
TrkA receptors
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage as Solution: Up to four weeks at 4°C or three months at -20°C. - Storage after Reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods (up to 6 months), small aliquots should be stored at -20°C. We do not recommend storing the product in working solutions for longer than a few days. Avoid multiple freeze-thaw cycles.
Molecular Weight
311, 8
Manufacturer - Format
Lyophilized powder.
Short description
A Potent Inhibitor of TrkA
Description
A Potent Inhibitor of TrkA
Reconstitution
4-10 mM in H2O. Centrifuge all product preparations before use (5, 000 x g for 1 min).
PH
7, 4
UNSPSC
41116134
Effective Concentration
2 nM - 2 µM.
Activity
GW441756 is a potent, selective inhibitor of the NGF receptor tyrosine kinase A (TrkA)1.
Solubility
4-10 mM in H2O. Centrifuge all product preparations before use (5, 000 x g for 1 min).
Bioassay tested
Yes
Chemical Name
(3Z)-3-[(1-methylindol-3-yl)methylidene]-1H-pyrrolo[3, 2-b]pyridin-2-one; hydrochloride.
Scientific Background
GW441756 is a potent and selective inhibitor of the NGF receptor tyrosine kinase A (TrkA). This compound also inhibits TrkB and TrkC but displays significantly higher selectivity for TrkA receptor than other TrkA inhibitors and a 100-fold selectivity over a range of other kinases. The IC50 value of GW441756 is 2 nM1, 3.The compound induces a dose-dependent decrease in neoplastic proliferation and has the ability to increase levels of caspase-3 that can lead to apoptosis.Previous studies have shown that TrKA inhibitors have a relevant anti-proliferative effects in neoplasia compare to other TrkA inhibitors with a lower effective dosage1, 3.Signaling through protein tyrosine kinase receptors is important for neuronal metabolism, promotion of neuronal survival, stimulating neurite growth, synaptogenesis and potentiating synaptic strength2.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 25 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen